Viewing StudyNCT06468033

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06468033
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-21
First Post: 2024-06-10
Brief Title: P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Sponsor: PharmaEssentia
Organization: PharmaEssentia
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Primary Myelofibrosis
Myeloproliferative Neoplasm
Keywords:
Name View
P1101 View
Primary Myelofibrosis View
PMF View
Ropeginterferon View
PharmaEssentia View
Myeloproliferative neoplasms View
MPN View
Pre-fibrotic View
Low or Intermediate-1 Risk View